Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014

Jun 25, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24

Reporting Person: Petersen Floyd F. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	32955	Direct
Common Stock	5457	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$11.68	2015-12-18	Common Stock (38462)		Direct
Stock Option (Right to Buy)	$10.77	2017-12-15	Common Stock (39312)		Direct
Stock Option (Right to Buy)	$14.66	2018-12-20	Common Stock (29278)		Direct

Footnotes

F1: This represents deferred stock units that were granted on 12/20/2013 and fully vest on the first anniversary of the grant date.

F2: This option is fully vested and exercisable.

F3: This option was granted on 12/20/2013 and fully vests on the first anniversary of the grant date, subject to the reporting person's continued (i) employment with or service to the Issuer or subsidiary thereof and (ii) service on the Board of Directors of the Issuer, in each case through the vesting date.